New Omicron-targeting antibody therapy for COVID authorized by FDA
• https://newatlas.com By Rich HaridyThe U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for bebtelovimab, a new monoclonal antibody designed to reduce risk of hospitalization and death from COVID-19.